Skip to content

Lifecore Biomedical, Inc. LFCR Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Baxter International logo
Baxter InternationalBAX
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
Biodesix, Inc. logo
Biodesix, Inc.BDSX
ClearPoint Neuro logo
ClearPoint NeuroCLPT
Charles River Laboratories logo
Charles River LaboratoriesCRL

Other financials

Income statement

See full
Revenue$23.2M-36.4%
Gross profit$4.5M-68.1%
Operating income-$4.7M
Net income-$15.0M-1,206%
EPS (diluted)-$0.43-1,333%

Balance sheet

See full
Cash & equivalents$20.8M+152%
Total debt$156.9M+1,310%
Total equity-$28.4M-2,229%
Total assets$225.5M-5.8%

Cash flow

See full
Operating cash flow$4.7M
CapEx$1.1M-46.7%
Free cash flow$3.6M

Valuation

See full
Market cap$196.92M-35.4%
Enterprise value$333.06M+8.3%
P/S1.6×+0.5×

Profitability

See full
Gross margin31.3%-1.4pp
Operating margin-14.5%-2.2pp
Net margin-30%
FCF margin-36.4%

Returns & leverage

See full
Return on equity-612.1%
Debt / equity8.3×-1.5×
Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s deferred tax assets and other non-current assets?
Lifecore Biomedical, Inc. (LFCR) reported deferred tax assets and other non-current assets of $8.47M in Q1 2026.
How has Lifecore Biomedical, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
Lifecore Biomedical, Inc.'s deferred tax assets and other non-current assets increased by 28.7% year-over-year, from $6.58M to $8.47M.
What is the long-term trend for Lifecore Biomedical, Inc.'s deferred tax assets and other non-current assets?
Over 5 years (2021 to 2026), Lifecore Biomedical, Inc.'s deferred tax assets and other non-current assets has grown at a 19.9% compound annual growth rate (CAGR), from $3.42M to $8.47M.